Hyundai Pharmaceutical's hair loss treatment 20,000 bottles are recalled

COMPANY / Reporter Kim Jisun / 2023-07-03 05:10:44

 

[Alpha Biz=(Chicago) Reporter Kim Jisun] Hyundai Pharmaceutical is collecting the drug after it was reported that the hair loss treatment drug on sale is mixed with dementia treatment.

It is known that the products subject to recall are mixed with dementia treatments. This was revealed through a pharmacist's report. About 20,000 bottles of recalled products are said to have been produced.

The Ministry of Food and Drug Safety and Hyundai Pharmaceutical are announcing the recall of the product in question through the company's website. Separately, the Ministry of Food and Drug Safety is investigating how the incident occurred and whether consumers took it.

 

Alphabiz Reporter Kim Jisun(stockmk2020@alphabiz.co.kr)

어플

주요기사

Bithumb Faces ‘Book-Entry Trading’ Concerns After Miscrediting Hundreds of Thousands of Bitcoins
Kolmar Korea Certified as Year’s First ‘Reshoring’ Company; To Invest 100 Billion KRW in Smart Factory Expansion
Court Dismisses Additional Lawsuits by Shareholders Over "Invossa" Controversy, Ruling in Favor of Kolon
Nvidia Delays China H200 Chip Exports Amid Ongoing Talks With U.S. Government
Naver Issues Formal Apology Over Exposure of Celebrities’ and Politicians’ Past "Ji-sik-iN" Posts
뉴스댓글 >

건강이 보이는 대표 K Medical 뉴스

SNS